These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 9306401)
1. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401 [TBL] [Abstract][Full Text] [Related]
2. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo. Bilbao G; Feng M; Rancourt C; Jackson WH; Curiel DT FASEB J; 1997 Jul; 11(8):624-34. PubMed ID: 9240964 [TBL] [Abstract][Full Text] [Related]
3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
4. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320 [TBL] [Abstract][Full Text] [Related]
5. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression. Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874 [TBL] [Abstract][Full Text] [Related]
6. Construction of new retroviral producer cells from adenoviral and retroviral vectors. Lin X Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327 [TBL] [Abstract][Full Text] [Related]
8. Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. Chester J; Ruchatz A; Gough M; Crittenden M; Chong H; Cosset FL; Diaz RM; Harrington K; Alvarez-Vallina L; Vile R Nat Biotechnol; 2002 Mar; 20(3):256-63. PubMed ID: 11875426 [TBL] [Abstract][Full Text] [Related]
9. Adeno-retroviral chimeric viruses as in vivo transducing agents. Caplen NJ; Higginbotham JN; Scheel JR; Vahanian N; Yoshida Y; Hamada H; Blaese RM; Ramsey WJ Gene Ther; 1999 Mar; 6(3):454-9. PubMed ID: 10435096 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218 [TBL] [Abstract][Full Text] [Related]
11. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634 [TBL] [Abstract][Full Text] [Related]
12. Stable and strictly controlled expression of LTR-flanked autoregulated expression cassettes upon adenoviral transfer. Unsinger J; Lindenmaier W; May T; Hauser H; Wirth D Biochem Biophys Res Commun; 2004 Jul; 319(3):879-87. PubMed ID: 15184065 [TBL] [Abstract][Full Text] [Related]
13. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Gu J; Zhang L; Huang X; Lin T; Yin M; Xu K; Ji L; Roth JA; Fang B Oncogene; 2002 Jul; 21(31):4757-64. PubMed ID: 12101414 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy. Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645 [TBL] [Abstract][Full Text] [Related]
16. Green fluorescent protein in retroviral vector constructs as marker and reporter of gene expression for cell and gene therapy applications. Eliopoulos N; Galipeau J Methods Mol Biol; 2002; 183():353-71. PubMed ID: 12136771 [No Abstract] [Full Text] [Related]
17. Exogenous peptide and protein expression levels using retroviral vectors in human cells. Sandrock TM; Risley B; Richards BT; Poritz MA; Austin HA; Yoo S; Kim MK; Roth B; Repetny K; Hsu F; Stump M; Teng DH; Kamb A Mol Ther; 2001 Nov; 4(5):398-406. PubMed ID: 11708876 [TBL] [Abstract][Full Text] [Related]
18. Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates. Roberts ML; Athanasopoulos T; Pohlschmidt M; Duisit G; Cosset FL; Dickson G Gene Ther; 2001 Oct; 8(20):1580-6. PubMed ID: 11704819 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous flow cytometric analyses of enhanced green and yellow fluorescent proteins and cell surface antigens in doubly transduced immature hematopoietic cell populations. Stull RA; Hyun WC; Pallavicini MG Cytometry; 2000 Jun; 40(2):126-34. PubMed ID: 10805932 [TBL] [Abstract][Full Text] [Related]
20. Reliable generation of stable high titer producer cell lines for gene therapy. Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]